Simplification of first-line antibacterial regimen for complicated appendicitis in children is associated with better adherence to guidelines and reduced use of antibiotics

Int J Antimicrob Agents. 2018 Aug;52(2):293-296. doi: 10.1016/j.ijantimicag.2018.04.010. Epub 2018 Apr 18.

Abstract

Acute appendicitis in children requires early surgery and short-course antibiotics active against Enterobacteriaceae and anaerobes. Although an aminoglycoside-containing three-drug regimen has been used successfully for decades, simpler regimens with similar efficacy are increasingly used. This study evaluated the impact of a switch from the combination of cefotaxime, metronidazole and gentamicin (regimen 1) to piperacillin/tazobactam (regimen 2) as first-line regimen for complicated acute appendicitis in children. In total, 171 children were enrolled [median (IQR) age, 10 (6-13) years], treated with regimen 1 (n = 80) or regimen 2 (n = 91) following surgery for complicated acute appendicitis. The two groups were comparable except for surgical approach (through laparoscopy in 46% vs. 88% for regimens 1 and 2, respectively; P < 0.001). Post-operative complications and duration of hospital stay were similar. Deviations from antibacterial treatment protocol decreased from 36% (29/80) to 14% (13/91) (P < 0.001), with a dramatic reduction in antibacterial treatment duration from median (IQR) of 15 (12-16) days to 5 (5-8) days (P < 0.001). Post-operative intra-abdominal abscess developed in 32 children (18.7%). Female sex (OR = 2.76, 95% CI 1.18-6.48; P = 0.02) and sepsis/septic shock on admission (OR = 4.72, 95% CI 1.12-19.97; P = 0.035) were independently associated with post-operative intra-abdominal abscess, but not antibacterial regimen. This study shows that simplification of first-line antibacterial regimen for complicated appendicitis in children was associated with reduced protocol deviation, reduced duration of antibiotics, and similar outcomes (post-operative complications and duration of hospital stay).

Keywords: Adherence; Aminoglycoside; Antimicrobial stewardship; Appendicitis; Piperacillin/tazobactam; Protocol.

Publication types

  • Observational Study

MeSH terms

  • Adolescent
  • Anti-Bacterial Agents / therapeutic use*
  • Appendicitis / complications*
  • Appendicitis / drug therapy
  • Appendicitis / microbiology
  • Appendicitis / surgery
  • Cefotaxime / therapeutic use
  • Child
  • Drug Therapy, Combination
  • Female
  • Gentamicins / therapeutic use
  • Guideline Adherence / statistics & numerical data*
  • Humans
  • Length of Stay / statistics & numerical data
  • Male
  • Metronidazole / therapeutic use
  • Penicillanic Acid / analogs & derivatives*
  • Penicillanic Acid / therapeutic use
  • Peritonitis / drug therapy*
  • Peritonitis / etiology
  • Peritonitis / microbiology
  • Peritonitis / pathology
  • Piperacillin / therapeutic use
  • Piperacillin, Tazobactam Drug Combination
  • Postoperative Complications / microbiology*
  • Postoperative Complications / pathology
  • Practice Guidelines as Topic
  • Retrospective Studies

Substances

  • Anti-Bacterial Agents
  • Gentamicins
  • Metronidazole
  • Piperacillin, Tazobactam Drug Combination
  • Penicillanic Acid
  • Cefotaxime
  • Piperacillin